TRPA1 and inflammatory bowel disease: The TNF-α level in the peripheral blood mononuclear cell supernatants of patients with inflammatory bowel disease (IBD) is elevated, and the presence of TRPA1 antagonists abolishes the inflammatory effects of TNF-α (Campaniello et al., 2017).